

Learn about common and serious Carbamazepine side effects, including what's normal, what's dangerous, and when to call your doctor right away.
Every medication comes with potential side effects, and Carbamazepine is no exception. The good news is that most people tolerate Carbamazepine well, especially after the first few weeks. But this medication does carry some serious risks that every patient should understand — including two FDA boxed warnings.
This guide breaks down the common side effects you can expect, the serious ones to watch for, and exactly when you should call your doctor.
Carbamazepine is an anticonvulsant medication sold under brand names like Tegretol, Tegretol XR, Carbatrol, and Equetro. It's FDA-approved to treat epilepsy (partial and generalized tonic-clonic seizures), trigeminal neuralgia, and acute manic episodes in bipolar I disorder. For a deeper dive, see our guide on what Carbamazepine is and how it works.
These side effects are the most frequently reported and are usually mild to moderate. Many improve within the first few weeks as your body adjusts to the medication.
Most of these common side effects are dose-related — meaning they're more likely at higher doses and may improve if your doctor adjusts your dosing schedule. Starting at a low dose and increasing slowly (which is standard practice with Carbamazepine) helps minimize these effects.
Carbamazepine carries two FDA boxed warnings — the most serious safety alerts the FDA issues. While these serious side effects are uncommon, they can be life-threatening and require immediate medical attention.
Carbamazepine can cause Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) — rare but potentially fatal skin reactions.
Carbamazepine can cause aplastic anemia (bone marrow failure) and agranulocytosis (dangerously low white blood cells). The risk is 5–8 times greater than in the general population.
Older adults are at increased risk for hyponatremia (low sodium) and may experience more pronounced dizziness, drowsiness, and confusion. Lower starting doses and more frequent monitoring are typically recommended.
Carbamazepine is Pregnancy Category D — it may cause fetal harm, including neural tube defects like spina bifida. If you're pregnant or planning to become pregnant, discuss the risks with your doctor. In some cases, the benefits of seizure control may outweigh the risks. Carbamazepine does pass into breast milk, so breastfeeding decisions should be made with your doctor.
Side effects in children are similar to adults, but parents should be especially watchful for rashes, behavioral changes, and signs of blood disorders. Pediatric dosing is weight-based and should be carefully managed by a pediatric neurologist.
If you're experiencing side effects, here are some practical strategies:
If side effects are significantly affecting your quality of life, talk to your doctor. Dose adjustments, formulation changes, or switching to an alternative like Oxcarbazepine or Lamotrigine may be options.
Most people taking Carbamazepine experience only mild, temporary side effects that improve as their body adjusts. The key is knowing what's normal (dizziness, drowsiness, mild nausea) versus what requires immediate attention (rash, unexplained fever, easy bruising, or mood changes).
Keep all your monitoring appointments, don't skip blood tests, and communicate openly with your doctor about how you're feeling. Carbamazepine is an effective medication when properly managed.
Need to fill your Carbamazepine prescription? Medfinder can help you find a pharmacy with it in stock near you. For more information, explore our guides on how Carbamazepine works and Carbamazepine drug interactions.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.